@ericroeland.bsky.social
@mazietsangmd.bsky.social
@ascocancer.bsky.social
@darcyburbage.bsky.social
@rsedhom.bsky.social
@ericroeland
#PallOnc MD improving the lives of people with cancer through #SymptomScience #ClinicalTrials #ASCOGuidelines | #CancerCachexia #irAE #PalliativeCare #SuppOnc | Member #OncSky #ASCO #ASPIRE #AAHPM #MASCC | skier, nature lover | views are mine
@ericroeland.bsky.social
@mazietsangmd.bsky.social
@ascocancer.bsky.social
@darcyburbage.bsky.social
@rsedhom.bsky.social
Join us this Thursday to hear the highlights from #ASCOQLTY25 with #ASCOQLTY Chair Elect
@ryannipp.bsky.social
DM for the link or to be added to our mailing list.
@realbowtiedoc.bsky.social
@crisbergerot.bsky.social
@ericroeland.bsky.social
@fionnualacrowley.bsky.social
#pallonc
ποΈ"Failure to deliver patient-centered care near the end of life βmeaning care that people wantβ remains a key shortcoming of our cancer care delivery system.β
Discussing a new RCT to improve advanced care planning.
π¨ NEW Podcast alert @ascocancer.bsky.social @oncoalert.bsky.social
Mark your calendars for the year. DM to be added to our mailing list and never miss a meeting:
@crisbergerot.bsky.social
@realbowtiedoc.bsky.social
@tingtingzhang.bsky.social
@ericroeland.bsky.social
@mazietsangmd.bsky.social
@ascocancer.bsky.social
@darcyburbage.bsky.social
@rsedhom.bsky.social
This Thursday!! Join us for our kick-off meeting with our leaders @crisbergerot.bsky.social and @realbowtiedoc.bsky.social. DM for link
@tingtingzhang.bsky.social
@fionnualacrowley.bsky.social
@ericroeland.bsky.social
@mazietsangmd.bsky.social
@ascocancer.bsky.social
@darcyburbage.bsky.social
New guideline alert for oncology professionals! π¨ ASCO & ONS just dropped their "Management of Antineoplastic Extravasation" guideline. Get the latest on antidotes, thermal compresses, and surgical referrals for extravasation.
Read it here: brnw.ch/21wVTFD
π’ Join us for ASPIRE Consortium's Global Session π Collaborating Across Europe: Advancing Care for irAEs
ποΈ Featuring @drjnaidoo.bsky.social + panel
π
Sept 15, 2025
π Time: 15:00β16:00 (Central US Time)
π» Zoom Link: partners.zoom.us/j/82978479128
π’ Meeting ID: 829 7847 9128
@ascocancer.bsky.social
For those dealing with the treatment-induced, menopause-y side effects of treatment for HR+ breast cancer like hot flashes and REALLY crappy sleep, this is a very interesting (and hopeful!) study
#CanSky #MakeCancerLessShitty #QoL
Phase 3 #SymptomScience @nejm.org RCT of elinzanetant vs placebo for moderate-to-severe vasomotor symptoms in HR+ #breast cancer (n=474) @ascocancer.bsky.social @cancercaremascc.bsky.social @hoperugo.bsky.social @coffeemommy.bsky.social @stage4kelly.bsky.social www.nejm.org/doi/full/10....
A summer π of firsts. Overjoyed to share my #inaugural editorial with π₯ peer mentor @mazietsangmd.bsky.social
in JCO-OP @ascocancer.bsky.social
π€β±οΈ #Wearable tech is transforming #SuppOnc and how we assess patient fitness ποΈββοΈ
π: ascopubs.org/doi/10.1200/...
In @nytopinion.bsky.social βMy sonβs life depends on government assistance,β writes Rachel Roth Aldhizer. βRecent cuts to Medicaid at both the federal and state levels mean millions of families like mine could soon be at a loss for how to care for our disabled loved ones.β
Please join us in congratulating Alice Shaw, MD, PhD, on being named our next Chair of the Department of Medical Oncology.
Learn more: bit.ly/45wiiQ6
A pleasure and an honor to join @fumikochino.bsky.social & Dr. Ethan Ludmir in this @ascocancer.bsky.social conversation on incomplete reporting and toxicity- minimizing language in oncology! π
Excited to head out this week to share the #BestofASCO in #pallonc and #supponc later this week. Join us!
@fumikochino.bsky.social
@tingtingzhang.bsky.social
@ericroeland.bsky.social
@darcyburbage.bsky.social
@oncoalert.bsky.social
@weoncologists.bsky.social
@pallonccop.bsky.social
Thank you Sesttle!
After a fabulous time at #MASCC25, I'm heading home with a full heart & mind. Grateful to all those working to improve supportive care in cancer & thrilled to have had yet another opportunity to share our advocate-led research on the main stages!
Safe travels to all π
π¨CMS just announced a model to introduce new #priorauthorization barriers to Traditional Medicare (which classically hasn't faced any).
We need less #priorAuth, not more.
Don't let this title fool you.
This is a "fix" for a problem that doesn't exist.
@ascocancer.bsky.social
@astro-org.bsky.social
Kicking off Day 2 of #MASCC25 with "Workshop 3: Beyond Survivorship 101: Building advanced skills in survivorship care" led by Dr Larissa Nekhlyudov,
@darcyburbage.bsky.social and @michael-jefford.bsky.social
A woman in front of a busy street with a sign for "Public Market Center"
"Every patient with cancer needs supportive care"
Good morning #mascc25! We're in Seattle for the premiere conference in #supponc discussing toxicity management and quality of life.
But first... breakfast and coffee at Pike Place Market βοΈπ₯π³ @cancercaremascc.bsky.social
Shout out to @stage4kelly.bsky.social on her e-poster presentation on the Patient Centered Dosing Initiative at
#MASCC25
And kudos to all co-authors and supporters of PCDI
Kudos and gratitude to the organizers, attendees, and fellow faculty members for today's Workshop 1: Partnering with patients in managing chronic toxicities of cancer and its treatment #MASCC25
@maryamlustberg.bsky.social @tingtingzhang.bsky.social @ericroeland.bsky.social @brueraeduardo.bsky.social
MASCC WS1 group
Stage4Kelly X post
Dr Bruera!
βΊοΈ MASCC LOC
Grateful for the insights and discussions shared with the stellar panelists and engaged audience at #MASCC25 workshop for cancer treatment toxicities. @maryamlustberg.bsky.social @ericroeland.bsky.social @coffeemommy.bsky.social and Dr Eduardo Bruera with screenshot from @stage4kelly.bsky.social
In 2025, we welcome and congratulate our inaugural cohort of MASCC Fellows (FMASCC). Fellow status is awarded to individuals who have made a sustained contribution to MASCC and demonstrated a continued high level of excellence in cancer supportive care practice and/or research.
#MASCC25
@drnataliagandur.bsky.social
@kjankovic.bsky.social
@elisaagostinetto.bsky.social
@joanmancusombc.bsky.social
@ascocancer.bsky.social
@crisbergerot.bsky.social
@tingtingzhang.bsky.social
@fionnualacrowley.bsky.social
@ericroeland.bsky.social
@mazietsangmd.bsky.social
@darcyburbage.bsky.social
What every doctor and nurse should know about radiation oncology when caring for individuals with serious illness. #medsky
geripal.org/what-you-sho...
@coffeemommy.bsky.social @stage4kelly.bsky.social @bogda-koczwara.bsky.social @maryamlustberg.bsky.social
@tingtingzhang.bsky.social @joannebowen.bsky.social
π Stay ahead in cancer care!β¨ For the latest @ascocancer.bsky.social #guidelines, check out this must-bookmark webpage: ascopubs.org/guidelines. Plus, don't miss the ASCO Guidelines App & cutting-edge AI assistant! Go-to resources for informed decisionsπ‘ @latinamd.bsky.social @beverlymoy.bsky.social
It's been my greatest joy to be a part of this community in my #earlycareer. Thanksful to have had the priveldge of leading with Dr @mazietsangmd.bsky.social and looking forward to this year with Dr @crisbergerot.bsky.social #pallonc #supponc
@tingtingzhang.bsky.social
@ericroeland.bsky.social
LIFE WITH OR AFTER CANCER Financial Toxicity and Breast Cancer: How Doctors Can Help Dr. Fumiko Chino offers advice and suggestions on how to navigate financial difficulties.
ποΈNew #ASCO25 podcast:
I was delighted to speak to BreastCancer.org to summarize my @ascocancer.bsky.social presentation on how doctors can help address the affordability gap. And what people with cancer should know about #financialToxicity in #breastcancer #bcsm
www.breastcancer.org/podcast/brea...
See you soon my @pallonccop.bsky.social friends. Here is a reel of our #ASCO25 gathering. Dr Thomas Smith at Johns Hopkins gave a great lecture and the president of @aahpm.bsky.social Dr Arif Kamal followed with a commentary on fostering a community of leaders. @ericroeland.bsky.social
Melanoma orals #8 β‘οΈ S2000 enco bini nivo vs ipi nivo in symptomatic melanoma brain mets
β‘οΈFirst randomized trial in symptomatic brain mets
β‘οΈSignificant PFS improvement with triple therapy over ipi nivo
β‘οΈNo significant OS benefit
Zeynep Eroglu, Moffitt #ASCO25 @ascocancer.bsky.social